Aptargroup Inc (ATR)
合理估值基本面
66
价格
$121.16
市值
$7.91B
第一部分 · 这家公司值多少
概览
AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
Generated on 2026年9月18日 with claude-haiku-4-5 — shared with all users
It supplies the elastomeric stoppers, seals and injection delivery systems that compete head-on with Aptar Pharma's injectables business for the same drug makers.
Through Silgan Dispensing Systems it makes the same pumps, trigger sprayers and dispensing closures Aptar sells to beauty, home care and food and beverage brands.
This French maker of nasal sprays, preservative-free eyedroppers and inhalers bids for the same drug-delivery device contracts with pharmaceutical companies as Aptar Pharma.
The German group sells inhalers, pen injectors and primary pharmaceutical packaging, and also cosmetics packaging, to the same pharma and beauty customers Aptar serves in Europe and the United States.
After absorbing Berry Global in April 2025 it is a large supplier of closures, dispensing components and healthcare packaging to the consumer and pharmaceutical brands Aptar depends on.
The privately held German closure specialist competes with Aptar's Food + Beverage segment on dispensing and non-dispensing plastic caps for drinks, edible oils and household liquids.
资产负债表与流动性
营收
$3.93B
最近12个月（截至2026/6/30）
净利润
$363M
最近12个月（截至2026/6/30）
自由现金流
$300M
股东权益合计
$2.67B
负债合计
$2.57B
流动比率
1.61
利息覆盖率
7.52
债务/EBITDA
1.79
每股收益
营收与净利润
自由现金流
收入构成
历史财务表
利润率变化
债务变化
债务负担有多重
增长一览表
增长 — 营业收入
公允价值估算
公允价值
$154.38
当前价格
$121.16
安全边际
+21.5%
公允价值区间
$116.80 - $191.96
所用估值方法之间的离散区间，并非经过统计校准的置信区间。
估算方法
估值指标
市盈率（P/E）
21.91
ROE
14.7%
市净率（P/B）
2.93
P/FCF
24.82
毛利率
-
ROIC
9.4%
盈利能力雷达图
价值创造（经济护城河）
ROIC
9.4%
WACC
7.2%
ROIC − WACC
+2.2 pp
ROIC 超过资本成本：公司正在为股东创造价值。
基本面分析标准
通过（21）
- EPS shows upward trend
- EPS CAGR 6.02%
- Price CAGR 5.45%
- ROIC 9.4%
- P/FCF 24.82
- P/B Ratio 2.93
- Debt/Equity ratio
- Operating Margin 12.1%
- Positive Free Cash Flow
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- ROE 13.6%
- Revenue Growth 5Y 5.2%
- Analyst Consensus 83% Buy
- Earnings Surprise avg 4.0%
- PEG Ratio 1.66
- Earnings Quality (OCF/NI) 1.61
- Share Dilution -1.5%
- Piotroski F-Score 5/9
未通过（5）
- CapEx intensity
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- Net Margin Trend 9.2% vs 10.8%
不可用（2）
- Gross Margin NaN%
- Dividend Payout NaN%
Piotroski F-评分
信号混杂：部分领域需关注
盈利质量
高质量：盈利有现金流支撑
股权稀释
正在回购股份，对股东友好
机构持股
该公司暂无机构申报数据。
公司治理
管理团队
| 姓名 | 职位 | 年龄 |
|---|---|---|
| Mr. Gael Touya | CEO, President & Director | 55 |
| Ms. Vanessa Kanu | Executive VP & CFO | 47 |
| Mr. Stephan B. Tanda | Director & Advisor | 60 |
| Mr. Marc Prieur | President of Aptar Beauty | 59 |
| Ms. Xiangwei Gong | Executive VP of Strategic Group Development & President of Aptar Asia | 55 |
| Mr. Hedi Tlili | President of Aptar Closures | 50 |
| Mr. Aditya J. Gandhi | VP, Principal Accounting Officer & Chief Accounting Officer | 45 |
| Ms. Mary Skafidas | Senior Vice President of Investor Relations & Communications | - |
| Ms. Irene Hudson | Executive VP, Chief Legal Officer & Corporate Secretary | 48 |
| Ms. Shiela Pallerne Vinczeller | Chief Human Resources Officer | 61 |
审计风险
1
董事会风险
1
薪酬风险
2
股东权利风险
5
第二部分 · 价格与买入时机
这一部分不判断公司是否值得拥有：它帮助你在基本面说服你之后，选择何时买入。包含：技术分析、潜力、历史回撤、Gamma 敞口。
损益历史
via SEC EDGAR
Latest News
Recent headlines for ATR, sourced from Markets Gazette.
- 28d agoPOSITIVEATR (JV Leonardo-Airbus), maxi ordine da 1 miliardo di dollari dall'indiana FLY91
Indian regional airline FLY91 has placed a landmark order for 40 ATR 72-600 aircraft, valued at approximately $1 billion. This significant deal represents the largest order for ATR globally from a single airline. The ATR 72-600 is a turboprop regional airliner, and this order underscores FLY91's commitment to expanding its regional network. For investors in Leonardo (a partner in the ATR joint venture), this order signals strong demand for regional aircraft and a positive outlook for the turboprop market, potentially boosting future revenues and profitability.
- 2/28/2026POSITIVERiver Road Loads Up on ATR With 917,000 Shares in New Position
River Road, a prominent investment manager, has announced the establishment of a new significant position in AptarGroup Inc., acquiring 917,000 shares. AptarGroup is a global provider of proprietary dispensing and sealing solutions for the healthcare, beauty, and consumer markets. This strategic move by River Road signals strong confidence in AptarGroup's future prospects, suggesting the company may be undervalued or poised for significant growth. Investors might interpret this as a bullish signal, indicating potential increased interest and demand for ATR shares, given its robust global market positioning.
via Markets Gazette